Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-26T18:55:54.442Z Has data issue: false hasContentIssue false
  • English
  • Français

Post Melody valve implant in a conduit with regurgitant native outflow tract successful closure by Amplatzer muscular device

Published online by Cambridge University Press:  17 January 2014

Tarek S. Momenah ,
Motea T. El Houry ,
Muhammad A. Khan  and
Mohammed O. Galal
Tarek S. Momenah*
Affiliation:
Department of Congenital & Structural Heart Disease, Prince Salman Heart Center, Riyadh, Saudi Arabia
Motea T. El Houry
Affiliation:
Department of Congenital & Structural Heart Disease, Prince Salman Heart Center, Riyadh, Saudi Arabia
Muhammad A. Khan
Affiliation:
Department of Congenital & Structural Heart Disease, Prince Salman Heart Center, Riyadh, Saudi Arabia
Mohammed O. Galal
Affiliation:
Department of Congenital & Structural Heart Disease, Prince Salman Heart Center, Riyadh, Saudi Arabia
*
Correspondence to: Dr T. S. Momenah, MBBS, DCH, FAAP, FRCP(C), FACC, FSCAI, Director of Hybrid Cath. Lab, Department of Congenital & Structural Heart Disease, Prince Salman Heart Center, Riyadh, Saudi Arabia. Tel: 00966-11-2889999; ext. 12099, 17351; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

We describe the technique of closure of native right ventricular outflow tract by Amplatzer muscular ventricular septal defect device because of severe regurgitation in a patient who had tetralogy of Fallot repair with conduit at 3 years of age followed by percutaneous Melody valve implant 6 years later.

Keywords

Tetralogy of Fallotmuscular VSDnative outflow tractMelody valve
Type
Original Articles
Information
Cardiology in the Young , Volume 25 , Issue 2 , February 2015 , pp. 324 - 327
Copyright
© Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Thanopoulos, B, Georgakopulos, D, Tsaousis, G, et al. A novel use of the Amplatzer muscular ventricular septal defect occluder. Cathet Cardiovasc Intervent 2002; 56: 234–237.CrossRefGoogle ScholarPubMed
2. Bonhoeffer, P, Boudjemline, Y, Saliba, Z, et al. Percutaneous replacement of pulmonary valve in the right ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000; 356: 1403–1405.Google Scholar
3. Lurz, P, Nordmeyer, J, Giardini, A, et al. Early versus later functional outcome after successful percutaneous pulmonary valve implantation: are the acute effects of altered right ventricular loading all we can expect? J Am Coll Cardiol 2011; 57: 724–731.CrossRefGoogle Scholar
4. Momenah, TS, El Oakley, R, Al Najashi, K, et al. Extended application of percutaneous pulmonary valve implantation. J Am Coll Cardiol 2009; 53: 1859–1863.Google Scholar
5. Nordmeyer, J, Tsang, V, Gaudin, R, et al. Quantitative assessment of homograft function 1 year after insertion into the pulmonary position: impact of in situ homograft geometry on valve competence. Eur Heart J 2009; 30: 2147–2154.Google Scholar
6. Bouzaz, B, Kilner, P, Gatzoulis, M. Pulmonary regurgitation: not a benign lesion. Eur Heart J 2005; 26: 433–439.Google Scholar
7. Dandolu, B, Baldwin, H, Norwood, W, et al. Tetralogy of Fallot with anomalous coronary artery: double outflow technique. Ann Thorac Surg 1999; 67: 1178–1180.Google Scholar
8. Tchervenko, C, Peeletier, M, Shum-Tim, D, et al. Primary repair minimizing the use of conduits in neonates and infants with tetralogy and or double-outlet right ventricular and anomalous coronary arteries. J Thorac Cardiovasc Surg 2000; 119: 314–323.Google Scholar